EFFECTS OF CASCADE FILTRATION IN COMBINATION WITH INTERFERON AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDER CHRONIC HEPATITIS C PATIENTS

被引：0
|
作者：
Ramunni, A. [1 ]
Brescia, P. [1 ]
Burzo, M. [1 ]
Verno, L. [1 ]
Rendina, M. [2 ]
机构：
[1] Dept Internal & Publ Med, Nephrol Sect, Bari, Italy
[2] Univ Bari, Dept Emergency & Organ Transplantat, Gastroenterol Sect, Bari, Italy
来源：
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 2010年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [31] Double filtration plasmapheresis and (PEG) interferon/ribavirin combination therapy in chronic hepatitis C patients
    Ide, T.
    Kaneko, S.
    Kakumu, S.
    Mochida, S.
    Sata, M.
    Fujiwara, K.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S227 - S228
  • [32] Efficacy of daily interferon-alpha-2b (IFN-A) in combination with Ribavirin in the treatment of non-responder patients with chronic hepatitis C (CHC): A randomised-controlled trial.
    Tassopoulos, NC
    Tsantoulas, D
    Raptopoulou, M
    Paraskevas, E
    Kanatakis, S
    Vafiadis, I
    Tzathas, C
    Avgerinos, A
    Sypsa, V
    Hatzakis, A
    HEPATOLOGY, 2000, 32 (04) : 354A - 354A
  • [33] Efficacy of daily interferon-alpha-2b (IFN-α) in combination with ribavirin in the treatment of non-responder patients with chronic hepatitis C (CHC):: A randomised-controlled trial.
    Tassopoulos, NC
    Tsantoulas, D
    Raptopoulou, M
    Paraskevas, E
    Vassiliadis, T
    Kanatakis, S
    Avgerinos, A
    Vafiadis, I
    Tzathas, C
    Ketikoglou, I
    Sypsa, V
    HEPATOLOGY, 2001, 34 (04) : 585A - 585A
  • [34] Chronic hepatitis C treatment guidelines need revision: A case of hepatitis C non-responder
    Khan, Mahboob A.
    Somers, William R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S386 - S387
  • [35] Retreatment for chronic hepatitis C of interferon non-responder patients.: Preliminary results of a multicenter randomized controlled trial of interferon plus ribavirin versus interferon alone.
    de Lédinghen, V
    Bernard, PH
    Trimoulet, P
    Bourlière, M
    Portal, I
    Rémy, AJ
    Szostak, N
    Longo, F
    Thiefin, G
    Abergel, A
    Dumas, F
    Lucidarme, D
    Blanc, P
    Zylberberg, H
    Capron, D
    Doll, J
    Fleury, H
    Couzigou, P
    HEPATOLOGY, 1998, 28 (04) : 374A - 374A
  • [36] Ribavirin and interferon∝-2b combination therapy for 48 weeks in patients with chronic hepatitis C who either failed (non-responder) or relapsed (relapsers) from previous interferon monotherapy.
    Tsai, NC
    Coste, A
    Shimoda, N
    Yee, H
    Jao, R
    Wong, L
    Buto, S
    Shimoda, S
    HEPATOLOGY, 1999, 30 (04) : 268A - 268A
  • [37] Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient
    Emara, Mohamed H.
    Radwan, Mohamed I.
    VIROLOGY JOURNAL, 2011, 8
  • [38] Antifibrogenic effect of combination interferon plus ribavirin treatment in patients with chronic hepatitis C
    Guido, M
    De Franceschi, L
    Felder, M
    Zagni, I
    Capelli, P
    Corrocher, R
    Rugge, M
    Cavallini, G
    Fattovich, G
    JOURNAL OF HEPATOLOGY, 2005, 42 : 206 - 206
  • [39] Amantadine in Non-Responder Patients with Chronic Hepatitis C: A Randomized Prospective Study
    Palabiyikoglu, Murat
    Ormeci, Necati
    Ekiz, Fuat
    Beyler, Ali Resit
    Erdem, Hakan
    Dokmeci, Abdulkadir
    Ozkan, Hasan
    Koklu, Seyfettin
    Coban, Sahin
    HEPATO-GASTROENTEROLOGY, 2012, 59 (118) : 1911 - 1914
  • [40] Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin
    Fujita, N.
    Kaito, M.
    Kai, M.
    Sugimoto, R.
    Tanaka, H.
    Horiike, S.
    Konishi, M.
    Iwasa, M.
    Watanabe, S.
    Adachi, Y.
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (07) : 441 - 448
12345